479 related articles for article (PubMed ID: 12208225)
1. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.
Wong CK; French JK; Krucoff MW; Gao W; Aylward PE; White HD
Eur Heart J; 2002 Sep; 23(18):1449-55. PubMed ID: 12208225
[TBL] [Abstract][Full Text] [Related]
2. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.
Wong CK; Gao W; Raffel OC; French JK; Stewart RA; White HD;
Lancet; 2006 Jun; 367(9528):2061-7. PubMed ID: 16798389
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction.
Wong CK; French JK; Aylward PE; Frey MJ; Adgey AA; White HD
Am J Cardiol; 1999 Jan; 83(2):164-8. PubMed ID: 10073815
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
Zeymer U; Schröder R; Tebbe U; Molhoek GP; Wegscheider K; Neuhaus KL
Eur Heart J; 2001 May; 22(9):769-75. PubMed ID: 11350109
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
White HD; Aylward PE; Frey MJ; Adgey AA; Nair R; Hillis WS; Shalev Y; Brown MA; French JK; Collins R; Maraganore J; Adelman B
Circulation; 1997 Oct; 96(7):2155-61. PubMed ID: 9337184
[TBL] [Abstract][Full Text] [Related]
7. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
[TBL] [Abstract][Full Text] [Related]
8. ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy.
Andrews J; Straznicky IT; French JK; Green CL; Maas AC; Lund M; Krucoff MW; White HD
Circulation; 2000 May; 101(18):2138-43. PubMed ID: 10801752
[TBL] [Abstract][Full Text] [Related]
9. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
10. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction.
Fernandez AR; Sequeira RF; Chakko S; Correa LF; de Marchena EJ; Chahine RA; Franceour DA; Myerburg RJ
J Am Coll Cardiol; 1995 Sep; 26(3):675-83. PubMed ID: 7642858
[TBL] [Abstract][Full Text] [Related]
11. [Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction].
Tomasević M; Kostić T; Apostolović S; Perisić Z; Djordjević-Radojković D; Koraćević G; Salinger-Martinović S
Srp Arh Celok Lek; 2008; 136(9-10):481-7. PubMed ID: 19069338
[TBL] [Abstract][Full Text] [Related]
12. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
White HD
Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893
[TBL] [Abstract][Full Text] [Related]
13. A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.
Lidón RM; Théroux P; Lespérance J; Adelman B; Bonan R; Duval D; Lévesque J
Circulation; 1994 Apr; 89(4):1567-72. PubMed ID: 8149522
[TBL] [Abstract][Full Text] [Related]
14. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction.
Karagounis L; Sorensen SG; Menlove RL; Moreno F; Anderson JL
J Am Coll Cardiol; 1992 Jan; 19(1):1-10. PubMed ID: 1729317
[TBL] [Abstract][Full Text] [Related]
15. Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.
White HD; Ellis CJ; French JK; Aylward P
Aust N Z J Med; 1998 Aug; 28(4):551-4. PubMed ID: 9777138
[TBL] [Abstract][Full Text] [Related]
16. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
French JK; Andrews J; Manda SO; Stewart RA; McTigue JJ; White HD
Am Heart J; 2002 Feb; 143(2):265-71. PubMed ID: 11835029
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Langer A; Krucoff MW; Klootwijk P; Veldkamp R; Simoons ML; Granger C; Califf RM; Armstrong PW
J Am Coll Cardiol; 1995 Jun; 25(7):1552-7. PubMed ID: 7759706
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
19. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction.
Schröder R; Dissmann R; Brüggemann T; Wegscheider K; Linderer T; Tebbe U; Neuhaus KL
J Am Coll Cardiol; 1994 Aug; 24(2):384-91. PubMed ID: 8034872
[TBL] [Abstract][Full Text] [Related]
20. In the transition from fibrinolysis to primary PCI, the HERO trials help refine STEMI ECG interpretation and Q wave analysis potentially alters future management.
Wong CK; White HD
Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(1_suppl):26-33. PubMed ID: 30117751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
